Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Park MH, Seo JH, Park JH, Seong MK, Park KU, Kim MK, Chang M, Koh SJ, Lee MH, Lim ST, Yoo YB, Oh SY, Kim SH, Ahn KY, Park TH, Ju H, Baek EH, Kim S, Kim N, Lee E, Kim TH.
Park MH, et al.
Expert Opin Biol Ther. 2024 Apr;24(4):305-312. doi: 10.1080/14712598.2024.2334386. Epub 2024 Apr 25.
Expert Opin Biol Ther. 2024.
PMID: 38664937